About
Technology
Issues
FAQ
Links
Official Page
Osimertinib as adjuvant therapy in patients (pts) with stage IB–IIIA EGFR mutation positive (EGFRm) NSCLC after complete tumor resection: ADAURA.
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.